Saccharin derivatives as inhibitors of interferon-mediated inflammation.
about
Saccharin: a lead compound for structure-based drug design of carbonic anhydrase IX inhibitors.HMGB1 Activates Proinflammatory Signaling via TLR5 Leading to Allodynia.Synthesis and crystal structure of new heterocyles derived from saccharin and uracil carrying 1,2,4-oxadiazolylmethyl group.Small-molecule inhibition of TLR8 through stabilization of its resting state.Saccharin Aza Bioisosteres-Synthesis and Preclinical Property Comparisons.
P2860
Saccharin derivatives as inhibitors of interferon-mediated inflammation.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Saccharin derivatives as inhibitors of interferon-mediated inflammation.
@ast
Saccharin derivatives as inhibitors of interferon-mediated inflammation.
@en
type
label
Saccharin derivatives as inhibitors of interferon-mediated inflammation.
@ast
Saccharin derivatives as inhibitors of interferon-mediated inflammation.
@en
prefLabel
Saccharin derivatives as inhibitors of interferon-mediated inflammation.
@ast
Saccharin derivatives as inhibitors of interferon-mediated inflammation.
@en
P2093
P2860
P356
P1476
Saccharin derivatives as inhibitors of interferon-mediated inflammation
@en
P2093
Adam Csakai
Alexander Martinko
Emily Davis
Sara Coulup
P2860
P304
P356
10.1021/JM500409K
P407
P577
2014-06-04T00:00:00Z